Cigna Corporation

Cigna has a documented pattern of regulatory violations across multiple domains, demonstrating systemic disregard for compliance. In September 2023, the company paid $172 million to resolve False Claims Act allegations that it submitted inaccurate and untruthful patient diagnosis data to the Centers for Medicare & Medicaid Services to inflate payments. This settlement included a five-year Corporate Integrity Agreement with the U.S. Department of Health and Human Services Office of Inspector General.

Separately, in May 2023, congressional committees launched probes following an investigation that found Cigna allowed its doctors to deny hundreds of thousands of claims per month using a system that did not require a review of patient medical records. In January 2024, the Connecticut Department of Financial Services issued a consent order to Cigna Health and Life Insurance Company following a regulatory review of its submissions. This pattern of significant settlements and ongoing regulatory scrutiny across different business functions indicates a compliance failure that extends beyond isolated incidents.